136 related articles for article (PubMed ID: 27583403)
21. Neuraminidase inhibitor therapy in a military population.
Fairchok MP; Chen WJ; Arnold JC; Schofield C; Danaher PJ; McDonough EA; Ottolini M; Mor D; Ridore M; Burgess TH; Millar EV
J Clin Virol; 2015 Jun; 67():17-22. PubMed ID: 25959151
[TBL] [Abstract][Full Text] [Related]
22. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
[TBL] [Abstract][Full Text] [Related]
23. In vitro neuraminidase inhibitory activities of four neuraminidase inhibitors against influenza viruses isolated in the 2010-2011 season in Japan.
Ikematsu H; Kawai N; Kashiwagi S
J Infect Chemother; 2012 Aug; 18(4):529-33. PubMed ID: 22370919
[TBL] [Abstract][Full Text] [Related]
24. Administration of neuraminidase inhibitors for the treatment of Japanese patients infected with the novel influenza A (H1N1).
Ohnishi K; Nakamura-Uchiyama F
J Infect Chemother; 2010 Feb; 16(1):62-3. PubMed ID: 20072797
[TBL] [Abstract][Full Text] [Related]
25. Neuraminidase inhibitors, superinfection and corticosteroids affect survival of influenza patients.
Lee N; Leo YS; Cao B; Chan PK; Kyaw WM; Uyeki TM; Tam WW; Cheung CS; Yung IM; Li H; Gu L; Liu Y; Liu Z; Qu J; Hui DS
Eur Respir J; 2015 Jun; 45(6):1642-52. PubMed ID: 25573405
[TBL] [Abstract][Full Text] [Related]
26. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against influenza virus isolates in the 2011-2012 season in Japan.
Ikematsu H; Kawai N; Iwaki N; Kashiwagi S
J Infect Chemother; 2014 Feb; 20(2):77-80. PubMed ID: 24560563
[TBL] [Abstract][Full Text] [Related]
27. Prompt use of neuraminidase inhibitors improves survival of children severely ill with flu.
McCarthy M
BMJ; 2013 Nov; 347():f7127. PubMed ID: 24285175
[No Abstract] [Full Text] [Related]
28. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.
Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC
Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442
[TBL] [Abstract][Full Text] [Related]
29. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S
Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968
[TBL] [Abstract][Full Text] [Related]
30. The truth about Tamiflu? Neuraminidase inhibitors in pandemic A/H1N1 flu.
Weber JT; Nicoll A; Bridges CB; Ciancio BC
BMJ; 2010 Jan; 340():c130. PubMed ID: 20071425
[No Abstract] [Full Text] [Related]
31. The chemiluminescent neuraminidase inhibition assay: a functional method for detection of influenza virus resistance to the neuraminidase inhibitors.
Okomo-Adhiambo M; Hurt AC; Gubareva LV
Methods Mol Biol; 2012; 865():95-113. PubMed ID: 22528155
[TBL] [Abstract][Full Text] [Related]
32. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of the influenza virus circulating in the Japanese 2013-2014 season.
Ikematsu H; Kawai N; Iwaki N; Kashiwagi S
J Infect Chemother; 2015 Sep; 21(9):634-8. PubMed ID: 26096495
[TBL] [Abstract][Full Text] [Related]
33. Anti-neuraminidase antibodies against pandemic A/H1N1 influenza viruses in healthy and influenza-infected individuals.
Desheva Y; Sychev I; Smolonogina T; Rekstin A; Ilyushina N; Lugovtsev V; Samsonova A; Go A; Lerner A
PLoS One; 2018; 13(5):e0196771. PubMed ID: 29742168
[TBL] [Abstract][Full Text] [Related]
34. The use of antiviral agents for the management of severe influenza.
Smith JR; Ariano RE; Toovey S
Crit Care Med; 2010 Apr; 38(4 Suppl):e43-51. PubMed ID: 19935416
[TBL] [Abstract][Full Text] [Related]
35. Global transmission of oseltamivir-resistant influenza.
Moscona A
N Engl J Med; 2009 Mar; 360(10):953-6. PubMed ID: 19258250
[No Abstract] [Full Text] [Related]
36. Antiviral treatment for patients hospitalized with 2009 pandemic influenza A (H1N1).
Uyeki T
N Engl J Med; 2009 Dec; 361(23):e110. PubMed ID: 19923564
[No Abstract] [Full Text] [Related]
37. Antiviral activity of baicalin against influenza A (H1N1/H3N2) virus in cell culture and in mice and its inhibition of neuraminidase.
Ding Y; Dou J; Teng Z; Yu J; Wang T; Lu N; Wang H; Zhou C
Arch Virol; 2014 Dec; 159(12):3269-78. PubMed ID: 25078390
[TBL] [Abstract][Full Text] [Related]
38. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of influenza virus in the Japanese 2012-2013 season.
Ikematsu H; Kawai N; Iwaki N; Kashiwagi S
J Infect Chemother; 2015 Jan; 21(1):39-42. PubMed ID: 25277670
[TBL] [Abstract][Full Text] [Related]
39. Morbidity and mortality associated with nosocomial transmission of oseltamivir-resistant influenza A(H1N1) virus.
Gooskens J; Jonges M; Claas EC; Meijer A; van den Broek PJ; Kroes AM
JAMA; 2009 Mar; 301(10):1042-6. PubMed ID: 19255111
[TBL] [Abstract][Full Text] [Related]
40. Early administration of neuraminidase inhibitors in adult patients hospitalized for influenza does not benefit survival: a retrospective cohort study.
Choi SH; Kim T; Park KH; Kwak YG; Chung JW; Lee MS
Eur J Clin Microbiol Infect Dis; 2017 Sep; 36(9):1673-1677. PubMed ID: 28417272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
